The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A
Open accessAbstract
Haemophilia A is a classic X-linked disease which affects 1 in 5–10,000 males in all populations1 and is caused by defects in coagulation factor VIII2,3. Roughly 60% of patients have severe disease with factor VIII activity <1% of normal; they have frequent spontaneous bleeding into joints, soft tissues, muscles and internal organs. These patients usually require regular injections of plasma-derived or recombinant human factor VIII. Because this is expensive and can potentially lead to life-threatening complications, other forms of therapy, includinggene therapy, have been proposed2. Natural canine models of factor VIII and factor IX deficiency have been available for many years4–5, and gene therapy attempts on these dogs have met with partial success6–8. However, a small animal model of the disease is desirable for studies of factor VIII function and gene therapy. Using gene targeting, we have made a mouse with severe factorVIII deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
Thomas, K. R., & Capecchi, M. R. (1987) · Cell · doi:10.1016/0092-8674(87)90646-5 · Cited by 2,355
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Site-directed mutagenesis of virtually any plasmid by eliminating a unique site
Deng, W. P., & Nickoloff, J. A. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90280-k · Cited by 1,060
Characterization of the human factor VIII gene
Gitschier, J., Wood, W. I., Goralka, T. M., Wion, K. L., Chen, E. Y., Eaton, D. H., Vehar, G. A., Capon, D. J., & Lawn, R. M. (1984) · Nature · doi:10.1038/312326a0 · Cited by 988
Proctor, R. R., & Rapaport, S. I. (1961) · American Journal of Clinical Pathology · doi:10.1093/ajcp/36.3.212 · Cited by 980
Molecular cloning of a cDNA encoding human antihaemophilic factor
Toole, J. J., Knopf, J. L., Wozney, J. M., Sultzman, L. A., Buecker, J. L., Pittman, D. D., Kaufman, R. J., Brown, E., Shoemaker, C., Orr, E. C., et al. (1984) · Nature · doi:10.1038/312342a0 · Cited by 925
Structure of human factor VIII
Vehar, G. A., Keyt, B., Eaton, D., Rodriguez, H., O'Brien, D. P., Rotblat, F., Oppermann, H., Keck, R., Wood, W. I., Harkins, R. N., et al. (1984) · Nature · doi:10.1038/312337a0 · Cited by 883
Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A
Lakich, D., Kazazian, H. H., Antonarakis, S. E., & Gitschier, J. (1993) · Nature Genetics · doi:10.1038/ng1193-236 · Cited by 788
Self-citationExpression of active human factor VIII from recombinant DNA clones
Wood, W. I., Capon, D. J., Simonsen, C. C., Eaton, D. L., Gitschier, J., Keyt, B., Seeburg, P. H., Smith, D. H., Hollingshead, P., Wion, K. L., et al. (1984) · Nature · doi:10.1038/312330a0 · Cited by 694
The Molecular Basis of Blood Diseases.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-6-950_3 · Cited by 632
In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient Dogs
Kay, M. A., Rothenberg, S., Landen, C. N., Bellinger, D. A., Leland, F., Toman, C., Finegold, M., Thompson, A. R., Read, M. S., Brinkhous, K. M., et al. (1993) · Science · doi:10.1126/science.8211118 · Cited by 304
Distribution of factor VIII mRNA and antigen in human liver and other tissues
Wion, K. L., Kelly, D., Summerfield, J. A., Tuddenham, E. G. D., & Lawn, R. M. (1985) · Nature · doi:10.1038/317726a0 · Cited by 296
Naylor, J., Brinke, A., Hassock, S., Green, P. M., & Giannelli, F. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.11.1773 · Cited by 259
Kay, M. A., Landen, C. N., Rothenberg, S. R., Taylor, L. A., Leland, F., Wiehle, S., Fang, B., Bellinger, D., Finegold, M., & Thompson, A. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2353 · Cited by 251
[49] Derivation of embryonic stem cell lines
Abbondanzo, S. J., Gadi, I., & Stewart, C. L. (1993) · Methods in Enzymology · doi:10.1016/0076-6879(93)25052-4 · Cited by 224
Guide to techniques in mouse development
Wassarman, P. M., & Depamphilis, M. (1993) · Cited by 218
An alternative approach to somatic cell gene therapy.
St Louis, D., & Verma, I. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3150 · Cited by 198
Canine hemophilia B resulting from a point mutation with unusual consequences.
Evans, J. P., Brinkhous, K. M., Brayer, G. D., Reisner, H. M., & High, K. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10095 · Cited by 189
Self-citationRosslter, J. P., Young, M., Kimberland, M. L., Hutter, P., Ketterling, R. P., Gitschier, J., Horst, J., Morris, M. A., Schaid, D. J., de Moerloose, P., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.7.1035 · Cited by 178
Self-citationRizza, C. R., & Spooner, R. J. D. (1983) · BMJ · doi:10.1136/bmj.286.6369.929 · Cited by 136
Molecular etiology of factor VIII deficiency in hemophilia A
Antonarakis, S. E., Kazazian, H. H., & Tuddenham, E. G. D. (1995) · Human Mutation · doi:10.1002/humu.1380050102 · Cited by 133
Self-citationInhibitors in hemophilia patients: Current status and management
Aledort, L. M. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830470312 · Cited by 86
Sequence of the Murine Factor VIII cDNA
Elder, B., Lakich, D., & Gitschier, J. M. (1993) · Genomics · doi:10.1006/geno.1993.1200 · Cited by 82
Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients.
Hoyer, L. W., & Scandella, D. H. (1994) · PubMed · Cited by 69
Clinical Application of a Chromogenic Substrate Method for Determination of Factor VIII Activity
Rosén, S., Andersson, M., Blombäck, M., Hégglund, U., Larrieu, M. J., Wolf, M., Boyer, C., Rothschild, C. W., Nilsson, I. M., Sjörin, E., et al. (1985) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1660140 · Cited by 63
Cited by
Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges
Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893
Self-citationAAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
Manno, C. S., Chew, A. J., Hutchison, S., Larson, P. J., Herzog, R. W., Arruda, V. R., Tai, S. J., Ragni, M. V., Thompson, A., Ozelo, M., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3296 · Cited by 749
Self-citationTissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis
Grover, S. P., & Mackman, N. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309846 · Cited by 667
Dahlbäck, B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02225-x · Cited by 610
Platelets in inflammation and thrombosis
Wagner, D. D., & Burger, P. C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000095974.95122.ec · Cited by 570
Metadata
- Authors
- Bi, L., Lawler, A. M., Antonarakis, S. E., High, K. A., Gearhart, J. D., & Kazazian, H. H.
- Venue
- Nature Genetics
- Published
- 1995-05
- Volume
- 10
- Issue
- 1
- Pages
- 119-121
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1964975805
- Cited by
- 593
- References
- 27
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.